World Pharma Today

Agilent Technologies Opens India Refurbishment Center to Advance Sustainable Science and Affordable Innovation New facility strengthens Agilent’s sustainability commitment and customer engagement; Education Center launched within integrated, green-certified...

Cardiovascular diseases, gastrointestinal conditions and cancer are top medical conditions expected to drive medical plan costs   Aon plc, a leading global professional services firm, today released the...

Symbiosis Pharmaceutical Services (Symbiosis), a global biopharmaceutical Contract Manufacturing Organisation (CMO) specialising in the sterile fill finish of injectable drug products, has been formally presented with a 2025...

With approximately 20 years of activity in the Indian market, Steriline has now reached 100 full line installations and aims for double-digit annual installations in 2026 Steriline, a...

Syntegon Delivers Strong Growth and Margin Expansion in Q3 2025 with Accelerating Pharma Momentum and Profitability Gains Across All Segments Q3 sales increased by 19% versus prior...

API China, the first and longest-running pharmaceutical ingredients exhibition in China brought in over 30,000 visitors and around 1,200 exhibitors between 12 and 14 November 2025 at...

Almac Group has announced a multi-million-pound investment to expand its facility in Singapore, as the company marks ten years of operations in the country. The investment by Almac...

Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase...

AI tools are boosting productivity, but researchers raise concerns about trust and transparency in answers, representing a missed opportunity for R&D In its latest report, Researcher of the Future,...

The global pharmaceutical industry is entering a pivotal phase...

Over more than ten years working in healthcare, medical...

Bringing a pharmaceutical product to market is hard work....

On February 17, 2026, GSK plc announced that the European Commission approves Exdensur - depemokimab in two indications - As an add-on maintenance treatment when it comes to critical...

In a move that is sure to create a stir within the Asia pharma circle, Sanofi Healthcare India - SHIPL is going ahead and expanding its GCC-...

Gilead Sciences has added another synthetic lethal asset to its oncology portfolio, agreeing to pay $80 million upfront to obtain global rights to a clinic-ready cancer therapy...

Results from the Phase III KALOS and LOGOS trials evaluating AstraZeneca Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF (320/28.8/9.6μg)) in patients with uncontrolled asthma have been published in...

The global pharmaceutical industry is entering a pivotal phase in obesity therapeutics as companies accelerate the transition from injectable GLP-1 drugs to oral weight-loss treatments, a shift...

An aging population is reshaping medicine. Why pharma must redesign drug development, trials, and coverage strategies to meet the real needs of patients 65+. Some may think that...

GCCL Co., Ltd. (GCCL) and Medicover Integrated Clinical Services (MICS), a division of Medicover, have entered into a Memorandum of Understanding (MOU) aimed at advancing multinational clinical...

Effective quality risk management in pharmaceutical manufacturing hinges on the availability of verified drug information to ensure GMP compliance and product safety.

Robust pharmacovigilance strategies rely on the continuous integration of high-quality drug interaction and safety data to protect patient health and ensure regulatory compliance.

While raw data is abundant, the strategic value of drug information lies in editorial curation, ensuring that every interaction, dosage, and safety alert is verified…